Literature DB >> 183389

Cytomegalovirus infection in children undergoing open-heart surgery.

J A Armstrong, G C Tarr, L A Youngblood, J N Dowling, A R Saslow, J P Lucas, M Ho.   

Abstract

A group of 124 children undergoing open-heart surgery was followed prospectively in order to estimate the risk of cytomegalovirus (CMV) infection due to transfused blood.Ninety-three patients (75%) had complement fixation (CF) titers of < 1:4 against CMV on admission. Of this seronegative subgroup, nine patients (9.7%) subsequently became infected with CMV. All nine showed seroconversion, and six were viruric 12-14 weeks after surgery. Comparative seroepidemiological studies of the hospital population showed that in the age ranges studied (3-16 yr), the infections seen in the study group represented a significant excess over expectation. This infection rate was consistent with a model of transmission by blood transfusion with a risk of 2.7% per unit but not proven.Thirty-one patients had CF antibody to CMV on admission. CMV was isolated from 14% of urines of seropositive children both before and after surgery, but only two patients showed CF antibody rises to CMV. Thus the frequency of CMV infection associated with open-heart surgery and transfusion could not be calculated in the seropositive subgroup.CMV infection was not related to the primary diagnosis or to Down's syndrome.

Entities:  

Mesh:

Year:  1976        PMID: 183389      PMCID: PMC2595348     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  14 in total

1.  Cytomegalovirus infection in a volunteer blood donor population.

Authors:  R C Kane; W E Rousseau; G R Noble; G E Tegtmeier; H Wulff; H B Herndon; T D Chin; W L Bayer
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  Seroepidemiology of infectious due to members of the herpesvirus group.

Authors:  B B Wentworth; E R Alexander
Journal:  Am J Epidemiol       Date:  1971-11       Impact factor: 4.897

Review 3.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

4.  A serologic study of cytomegalovirus infections associated with blood transfusions.

Authors:  A M Prince; W Szmuness; S J Millian; D S David
Journal:  N Engl J Med       Date:  1971-05-20       Impact factor: 91.245

5.  Latent cytomegalovirus infection in blood donors.

Authors:  P Diosi; E Moldovan; N Tomescu
Journal:  Br Med J       Date:  1969-12-13

6.  Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery.

Authors:  W Henle; G Henle; M Scriba; C R Joyner; F S Harrison; R Von Essen; J Paloheimo; E Klemola
Journal:  N Engl J Med       Date:  1970-05-07       Impact factor: 91.245

7.  Cytomegalovirus infection after renal allotransplantation.

Authors:  J E Craighead; J B Hanshaw; C B Carpenter
Journal:  JAMA       Date:  1967-09-04       Impact factor: 56.272

8.  Cytomegalovirus infection and cytomegalic inclusion disease in renal homotransplant recipients.

Authors:  R E Kanich; J E Craighead
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

9.  Rise of cytomegalovirus antibodies in an infectious-mononucleosis-like syndrome after transfusion.

Authors:  L Kääriäinen; E Klemola; J Paloheimo
Journal:  Br Med J       Date:  1966-05-21

10.  Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction.

Authors:  B C Wu; J N Dowling; J A Armstrong; M Ho
Journal:  Science       Date:  1975-10-03       Impact factor: 47.728

View more
  9 in total

1.  Virus infections after transplantation in man. Brief review.

Authors:  M Ho
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  Cytomegalovirus infection in heart transplant recipients: preliminary results of a controlled trial of intravenous gamma globulin.

Authors:  J K Preiksaitis; S Rosno; L Rasmussen; T C Merigan
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

Review 3.  Assessment of human cytomegalovirus antibody detection techniques.

Authors:  F Horodniceanu; S Michelson
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

4.  OKT3 and viral disease in pediatric liver transplant recipients.

Authors:  James S Bowman; Michael Green; Velma P Scantlebury; Saturo Todo; Andreas Tzakis; Shunzaburo Iwatsuki; Laura Douglas; Thomas E Starzl
Journal:  Clin Transplant       Date:  1991-08       Impact factor: 2.863

5.  Cytomegalovirus as a risk factor in living-related renal transplantation. A prospective study.

Authors:  R Pollak; P L Barber; B F Prusak; M F Mozes
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

Review 6.  Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies.

Authors:  Lauren Nassetta; David Kimberlin; Richard Whitley
Journal:  J Antimicrob Chemother       Date:  2009-03-14       Impact factor: 5.790

7.  Susceptibility of clinical isolates of cytomegalovirus to human interferon.

Authors:  B Postic; J N Dowling
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

8.  Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.

Authors:  N Singh; J S Dummer; S Kusne; M K Breinig; J A Armstrong; L Makowka; T E Starzl; M Ho
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

Review 9.  The history of cytomegalovirus and its diseases.

Authors:  Monto Ho
Journal:  Med Microbiol Immunol       Date:  2007-12-18       Impact factor: 3.402

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.